Dr. Thomas Lehmann
Leitender Arzt
Leitung Fachbereich Hämatologie
Medizinische Onkologie und Hämatologie · Dept. I
Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study.
Koster K, Messerich N, Volken T, Cogliatti S, Lehmann T, Graf L, Holbro A, Benz R, Demmer I, Jochum W, Rao T, Silzle T. Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study. Cancers (Basel) 2023; 15
24.09.2023Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study.
24.09.2023Cancers (Basel) 2023; 15
Koster Kira-Lee, Messerich Nora-Medea, Volken Thomas, Cogliatti Sergio B., Lehmann Thomas, Graf Lukas, Holbro Andreas, Benz Rudolf, Demmer Izadora, Jochum Wolfram, Rao Tata Nageswara, Silzle Tobias
Swiss Survey on current practices and opinions on clinical constellations triggering the search for PNH clones.
Rovó A, Gavillet M, Drexler B, Keller P, Schneider J, Colucci G, Beauverd Y, van Dorland H, Pollak M, Schmidt A, De Gottardi A, Bissig M, Lehmann T, Duchosal M, Zeerleder S. Swiss Survey on current practices and opinions on clinical constellations triggering the search for PNH clones. Front Med (Lausanne) 2023; 10:1200431.
26.07.2023Swiss Survey on current practices and opinions on clinical constellations triggering the search for PNH clones.
26.07.2023Front Med (Lausanne) 2023; 10:1200431
Rovó Alicia, Gavillet Mathilde, Drexler Beatrice, Keller Peter M, Schneider Jenny Sarah, Colucci Giuseppe, Beauverd Yan, van Dorland Hendrika Anette, Pollak Matthias, Schmidt Adrian, De Gottardi Andrea, Bissig Marina, Lehmann Thomas, Duchosal Michel A, Zeerleder Sacha
Treatment regimens in patients over 64 years with acute myeloid leukaemia: a retrospective single-institution, multi-site analysis.
Sutter T, Schittenhelm M, Volken T, Lehmann T. Treatment regimens in patients over 64 years with acute myeloid leukaemia: a retrospective single-institution, multi-site analysis. Hematology 2023; 28:2206694.
11.05.2023Treatment regimens in patients over 64 years with acute myeloid leukaemia: a retrospective single-institution, multi-site analysis.
11.05.2023Hematology 2023; 28:2206694
Sutter Tabea, Schittenhelm Marcus, Volken Thomas, Lehmann Thomas
CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70-A Retrospective Study.
Messerich N, Uda N, Volken T, Cogliatti S, Lehmann T, Holbro A, Benz R, Graf L, Gupta V, Jochum W, Demmer I, Rao T, Silzle T. CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70-A Retrospective Study. Cancers (Basel) 2023; 15
25.02.2023CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70-A Retrospective Study.
25.02.2023Cancers (Basel) 2023; 15
Messerich Nora-Medea, Uda Narasimha Rao, Volken Thomas, Cogliatti Sergio B., Lehmann Thomas, Holbro Andreas, Benz Rudolf, Graf Lukas, Gupta Vikas, Jochum Wolfram, Demmer Izadora, Rao Tata Nageswara, Silzle Tobias
Hematocrit Self-Testing in Patients with Polycythemia Vera and Other Hematological Conditions: Assessing the Accuracy of the StatStrip Xpress 2 LAC/Hb/Hct Device and User Opinion about the Device in Real-World Clinical Practice.
Rovó A, Baierlein-Leimbach C, Medri C, Chanias I, Errass L, Fehr T, Triemer T, McCarthy-Pontier D, Lehmann T. Hematocrit Self-Testing in Patients with Polycythemia Vera and Other Hematological Conditions: Assessing the Accuracy of the StatStrip Xpress 2 LAC/Hb/Hct Device and User Opinion about the Device in Real-World Clinical Practice. J Clin Med 2022; 11
21.07.2022Hematocrit Self-Testing in Patients with Polycythemia Vera and Other Hematological Conditions: Assessing the Accuracy of the StatStrip Xpress 2 LAC/Hb/Hct Device and User Opinion about the Device in Real-World Clinical Practice.
21.07.2022J Clin Med 2022; 11
Rovó Alicia, Baierlein-Leimbach Claudia, Medri Cesare, Chanias Ioannis, Errass Loreen, Fehr Theresa, Triemer Therese, McCarthy-Pontier Daphne B, Lehmann Thomas
Real-world Data From the Swiss Lenalidomide in MDS del(5q) (SLIM)-Registry Identify New Chances and Challenges in Lenalidomide Treatment of Patients With MDS del(5q).
Rüfer A, Angermann H, Benz R, Bonadies N, Calderoni A, Cantoni N, Efthymiou A, Escher R, Favre G, Friess D, Gschwend A, Himmelmann A, Holbro A, Keller P, Kouroupi E, Lehmann T, Pedarnig N, Rigamonti V, Samii K, Schmidt A, Schäfer H, Sperb R, Stussi G, Winkler A, Zenhäusern R, Goede J. Real-world Data From the Swiss Lenalidomide in MDS del(5q) (SLIM)-Registry Identify New Chances and Challenges in Lenalidomide Treatment of Patients With MDS del(5q). Hemasphere 2022; 6:e741.
17.06.2022Real-world Data From the Swiss Lenalidomide in MDS del(5q) (SLIM)-Registry Identify New Chances and Challenges in Lenalidomide Treatment of Patients With MDS del(5q).
17.06.2022Hemasphere 2022; 6:e741
Rüfer Axel, Angermann Hubert, Benz Rudolf, Bonadies Nicolas, Calderoni Antonello, Cantoni Nathan, Efthymiou Anna, Escher Robert, Favre Geneviève, Friess Dorothea, Gschwend Andreas, Himmelmann Andreas, Holbro Andreas, Keller Peter, Kouroupi Eirini, Lehmann Thomas, Pedarnig Nikolaus, Rigamonti Véronique, Samii Kaveh, Schmidt Adrian, Schäfer Hans-Peter, Sperb Roland, Stussi Georg, Winkler Annette, Zenhäusern Reinhard, Goede Jeroen
Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needs.
Scotch A, Kosiorek H, Scherber R, Dueck A, Slot S, Zweegman S, Boekhorst P, Commandeur S, Schouten H, Sackmann F, Fuentes A, Hernández-Maraver D, Pahl H, Griesshammer M, Stegelmann F, Döhner K, Lehmann T, Bonatz K, Reiter A, Boyer F, Etienne G, Ianotto J, Ranta D, Roy L, Cahn J, Harrison C, Radia D, Muxi P, Maldonado N, Besses C, Cervantes F, Johansson P, Barbui T, Barosi G, Vannucchi A, Paoli C, Passamonti F, Andreasson B, Ferrari M, Rambaldi A, Samuelsson J, Birgegard G, Xiao Z, Xu Z, Zhang Y, Sun X, Xu J, Kiladjian J, Zhang P, Gale R, Mesa R, Geyer H. Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needs. Leuk Res 2017; 63:34-40.
14.10.2017Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needs.
14.10.2017Leuk Res 2017; 63:34-40
Scotch Allison H, Kosiorek Heidi, Scherber Robyn, Dueck Amylou C, Slot Stefanie, Zweegman Sonja, Boekhorst Peter A W Te, Commandeur Suzan, Schouten Harry, Sackmann Federico, Fuentes Ana Kerguelen, Hernández-Maraver Dolores, Pahl Heike L, Griesshammer Martin, Stegelmann Frank, Döhner Konstanze, Lehmann Thomas, Bonatz Karin, Reiter Andreas, Boyer Francoise, Etienne Gabriel, Ianotto Jean-Christophe, Ranta Dana, Roy Lydia, Cahn Jean-Yves, Harrison Claire N, Radia Deepti, Muxi Pablo, Maldonado Norman, Besses Carlos, Cervantes Francisco, Johansson Peter L, Barbui Tiziano, Barosi Giovanni, Vannucchi Alessandro M, Paoli Chiara, Passamonti Francesco, Andreasson Bjorn, Ferrari Maria L, Rambaldi Alessandro, Samuelsson Jan, Birgegard Gunnar, Xiao Zhijian, Xu Zefeng, Zhang Yue, Sun Xiujuan, Xu Junqing, Kiladjian Jean-Jacques, Zhang Peihong, Gale Robert Peter, Mesa Ruben A, Geyer Holly L
Standardization of 8-color flow cytometry across different flow cytometer instruments: A feasibility study in clinical laboratories in Switzerland.
Glier H, Heijnen I, Hauwel M, Dirks J, Quarroz S, Lehmann T, Rovó A, Arn K, Matthes T, Hogan C, Keller P, Dudkiewicz E, Stussi G, Fernandez P. Standardization of 8-color flow cytometry across different flow cytometer instruments: A feasibility study in clinical laboratories in Switzerland. J Immunol Methods 2017; 475:112348.
29.07.2017Standardization of 8-color flow cytometry across different flow cytometer instruments: A feasibility study in clinical laboratories in Switzerland.
29.07.2017J Immunol Methods 2017; 475:112348
Glier Hana, Heijnen Ingmar, Hauwel Mathieu, Dirks Jan, Quarroz Stéphane, Lehmann Thomas, Rovó Alicia, Arn Kornelius, Matthes Thomas, Hogan Cassandra, Keller Peter, Dudkiewicz Ewa, Stussi Georg, Fernandez Paula
Anti-Platelet Factor 4/Heparin Antibody Formation Occurs Endogenously and at Unexpected High Frequency in Polycythemia Vera.
Meyer S, Steinmann E, Lehmann T, Muesser P, Passweg J, Skoda R, Tsakiris D. Anti-Platelet Factor 4/Heparin Antibody Formation Occurs Endogenously and at Unexpected High Frequency in Polycythemia Vera. Biomed Res Int 2017; 2017:9876819.
18.06.2017Anti-Platelet Factor 4/Heparin Antibody Formation Occurs Endogenously and at Unexpected High Frequency in Polycythemia Vera.
18.06.2017Biomed Res Int 2017; 2017:9876819
Meyer Sara C, Steinmann Eva, Lehmann Thomas, Muesser Patricia, Passweg Jakob R, Skoda Radek C, Tsakiris Dimitrios A
Trends of classification, incidence, mortality, and survival of MDS patients in Switzerland between 2001 and 2012.
Bonadies N, Feller A, Rovó A, Ruefer A, Blum S, Gerber B, Stuessi G, Benz R, Cantoni N, Holbro A, Schmidt A, Lehmann T, Wilk C, Arndt V, NICER Working Group. Trends of classification, incidence, mortality, and survival of MDS patients in Switzerland between 2001 and 2012. Cancer Epidemiol 2017; 46:85-92.
02.01.2017Trends of classification, incidence, mortality, and survival of MDS patients in Switzerland between 2001 and 2012.
02.01.2017Cancer Epidemiol 2017; 46:85-92
Bonadies Nicolas, Feller Anita, Rovó Alicia, Ruefer Axel, Blum Sabine, Gerber Bernhard, Stuessi Georg, Benz Rudolf, Cantoni Nathan, Holbro Andreas, Schmidt Adrian, Lehmann Thomas, Wilk C Matthias, Arndt Volker, NICER Working Group
Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group.
Geyer H, Kosiorek H, Dueck A, Scherber R, Slot S, Zweegman S, Te Boekhorst P, Senyak Z, Schouten H, Sackmann F, Fuentes A, Hernández-Maraver D, Pahl H, Griesshammer M, Stegelmann F, Döhner K, Lehmann T, Bonatz K, Reiter A, Boyer F, Etienne G, Ianotto J, Ranta D, Roy L, Cahn J, Harrison C, Radia D, Muxi P, Maldonado N, Besses C, Cervantes F, Johansson P, Barbui T, Barosi G, Vannucchi A, Paoli C, Passamonti F, Andreasson B, Ferrari M, Rambaldi A, Samuelsson J, Cannon K, Birgegard G, Xiao Z, Xu Z, Zhang Y, Sun X, Xu J, Kiladjian J, Zhang P, Gale R, Mesa R. Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group. Haematologica 2016; 102:85-93.
18.08.2016Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group.
18.08.2016Haematologica 2016; 102:85-93
Geyer Holly L, Kosiorek Heidi, Dueck Amylou C, Scherber Robyn, Slot Stefanie, Zweegman Sonja, Te Boekhorst Peter Aw, Senyak Zhenya, Schouten Harry, Sackmann Federico, Fuentes Ana Kerguelen, Hernández-Maraver Dolores, Pahl Heike L, Griesshammer Martin, Stegelmann Frank, Döhner Konstanze, Lehmann Thomas, Bonatz Karin, Reiter Andreas, Boyer Francoise, Etienne Gabriel, Ianotto Jean-Christophe, Ranta Dana, Roy Lydia, Cahn Jean-Yves, Harrison Claire N, Radia Deepti, Muxi Pablo, Maldonado Norman, Besses Carlos, Cervantes Francisco, Johansson Peter L, Barbui Tiziano, Barosi Giovanni, Vannucchi Alessandro M, Paoli Chiara, Passamonti Francesco, Andreasson Bjorn, Ferrari Maria L, Rambaldi Alessandro, Samuelsson Jan, Cannon Keith, Birgegard Gunnar, Xiao Zhijian, Xu Zefeng, Zhang Yue, Sun Xiujuan, Xu Junqing, Kiladjian Jean-Jacques, Zhang Peihong, Gale Robert Peter, Mesa Ruben A
Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease.
Geyer H, Scherber R, Kosiorek H, Dueck A, Kiladjian J, Xiao Z, Slot S, Zweegman S, Sackmann F, Fuentes A, Hernández-Maraver D, Döhner K, Harrison C, Radia D, Muxi P, Besses C, Cervantes F, Johansson P, Andreasson B, Rambaldi A, Barbui T, Bonatz K, Reiter A, Boyer F, Etienne G, Ianotto J, Ranta D, Roy L, Cahn J, Maldonado N, Barosi G, Ferrari M, Gale R, Birgegard G, Xu Z, Zhang Y, Sun X, Xu J, Zhang P, te Boekhorst P, Commandeur S, Schouten H, Pahl H, Griesshammer M, Stegelmann F, Lehmann T, Senyak Z, Vannucchi A, Passamonti F, Samuelsson J, Mesa R. Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease. J Clin Oncol 2015; 34:151-9.
23.11.2015Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease.
23.11.2015J Clin Oncol 2015; 34:151-9
Geyer Holly L, Scherber Robyn, Kosiorek Heidi, Dueck Amylou C, Kiladjian Jean-Jacques, Xiao Zhijian, Slot Stefanie, Zweegman Sonja, Sackmann Federico, Fuentes Ana Kerguelen, Hernández-Maraver Dolores, Döhner Konstanze, Harrison Claire N, Radia Deepti, Muxi Pablo, Besses Carlos, Cervantes Francisco, Johansson Peter L, Andreasson Bjorn, Rambaldi Alessandro, Barbui Tiziano, Bonatz Karin, Reiter Andreas, Boyer Francoise, Etienne Gabriel, Ianotto Jean-Christophe, Ranta Dana, Roy Lydia, Cahn Jean-Yves, Maldonado Norman, Barosi Giovanni, Ferrari Maria L, Gale Robert Peter, Birgegard Gunnar, Xu Zefeng, Zhang Yue, Sun Xiujuan, Xu Junqing, Zhang Peihong, te Boekhorst Peter A W, Commandeur Suzan, Schouten Harry, Pahl Heike L, Griesshammer Martin, Stegelmann Frank, Lehmann Thomas, Senyak Zhenya, Vannucchi Alessandro M, Passamonti Francesco, Samuelsson Jan, Mesa Ruben A
Temperature-Sensitive Indicators for Monitoring RBC Concentrates Out of Controlled Temperature Storage.
Sigle J, Holbro A, Lehmann T, Infanti L, Gerull S, Stern M, Tichelli A, Passweg J, Buser A. Temperature-Sensitive Indicators for Monitoring RBC Concentrates Out of Controlled Temperature Storage. Am J Clin Pathol 2015; 144:145-50.
01.07.2015Temperature-Sensitive Indicators for Monitoring RBC Concentrates Out of Controlled Temperature Storage.
01.07.2015Am J Clin Pathol 2015; 144:145-50
Sigle Joerg P, Holbro Andreas, Lehmann Thomas, Infanti Laura, Gerull Sabine, Stern Martin, Tichelli André, Passweg Jakob, Buser Andreas
Erythropoietin receptor mutation--a rush of blood to the head?
Holbro A, Skoda R, Lundberg P, Passweg J, Buser A, Lehmann T. Erythropoietin receptor mutation--a rush of blood to the head?. Ann Hematol 2015; 94:1229-31.
14.03.2015Erythropoietin receptor mutation--a rush of blood to the head?
14.03.2015Ann Hematol 2015; 94:1229-31
Holbro Andreas, Skoda Radek C, Lundberg Pontus, Passweg Jakob, Buser Andreas, Lehmann Thomas
Massive human rivaroxaban overdose.
Lehmann T, Hofer K, Baumann M, Hasler K, Ceschi A, Kupferschmidt H, Rohde G, Korte W. Massive human rivaroxaban overdose. Thromb Haemost 2014; 112:834-6.
24.07.2014Massive human rivaroxaban overdose.
24.07.2014Thromb Haemost 2014; 112:834-6
Lehmann Thomas, Hofer Katharina E, Baumann Michael, Hasler Karin, Ceschi Alessandro, Kupferschmidt Hugo, Rohde Gabriele, Korte Wolfgang
Harmlose blaue Flecken? Gerinnungsstörung trotz normaler INR
Greuter L, Schöb M, Lehmann T, Diethelm M. Harmlose blaue Flecken? Gerinnungsstörung trotz normaler INR. Praxis (Bern 1994) 2014; 103:899-902.
23.07.2014Harmlose blaue Flecken? Gerinnungsstörung trotz normaler INR
23.07.2014Praxis (Bern 1994) 2014; 103:899-902
Greuter Ladina, Schöb Manuela, Lehmann Thomas, Diethelm Markus
Activating mutations in STIM1 and ORAI1 cause overlapping syndromes of tubular myopathy and congenital miosis.
Nesin V, Wiley G, Kousi M, Ong E, Lehmann T, Nicholl D, Suri M, Shahrizaila N, Katsanis N, Gaffney P, Wierenga K, Tsiokas L. Activating mutations in STIM1 and ORAI1 cause overlapping syndromes of tubular myopathy and congenital miosis. Proc Natl Acad Sci U S A 2014; 111:4197-202.
03.03.2014Activating mutations in STIM1 and ORAI1 cause overlapping syndromes of tubular myopathy and congenital miosis.
03.03.2014Proc Natl Acad Sci U S A 2014; 111:4197-202
Nesin Vasyl, Wiley Graham, Kousi Maria, Ong E-Ching, Lehmann Thomas, Nicholl David J, Suri Mohnish, Shahrizaila Nortina, Katsanis Nicholas, Gaffney Patrick M, Wierenga Klaas J, Tsiokas Leonidas
Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms.
Lundberg P, Karow A, Nienhold R, Looser R, Hao-Shen H, Nissen I, Girsberger S, Lehmann T, Passweg J, Stern M, Beisel C, Kralovics R, Skoda R. Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms. Blood 2014; 123:2220-8.
29.01.2014Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms.
29.01.2014Blood 2014; 123:2220-8
Lundberg Pontus, Karow Axel, Nienhold Ronny, Looser Renate, Hao-Shen Hui, Nissen Ina, Girsberger Sabine, Lehmann Thomas, Passweg Jakob, Stern Martin, Beisel Christian, Kralovics Robert, Skoda Radek C
Lung histology predicts outcome of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
Holbro A, Lehmann T, Girsberger S, Stern M, Gambazzi F, Lardinois D, Heim D, Passweg J, Tichelli A, Bubendorf L, Savic S, Hostettler K, Grendelmeier P, Halter J, Tamm M. Lung histology predicts outcome of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2013; 19:973-80.
02.04.2013Lung histology predicts outcome of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
02.04.2013Biol Blood Marrow Transplant 2013; 19:973-80
Holbro Andreas, Lehmann Thomas, Girsberger Sabine, Stern Martin, Gambazzi Franco, Lardinois Didier, Heim Dominik, Passweg Jakob R, Tichelli André, Bubendorf Lukas, Savic Spasenija, Hostettler Katrin, Grendelmeier Peter, Halter Joerg P, Tamm Michael
Comparison of a powered bone marrow biopsy device with a manual system: results of a prospective randomised controlled trial.
Bucher C, Lehmann T, Tichelli A, Tzankov A, Dirnhofer S, Passweg J, Rovó A. Comparison of a powered bone marrow biopsy device with a manual system: results of a prospective randomised controlled trial. J Clin Pathol 2012; 66:24-8.
26.10.2012Comparison of a powered bone marrow biopsy device with a manual system: results of a prospective randomised controlled trial.
26.10.2012J Clin Pathol 2012; 66:24-8
Bucher Christoph, Lehmann Thomas, Tichelli André, Tzankov Alexander, Dirnhofer Stephan, Passweg Jakob, Rovó Alicia